How to Read a Peptide COA: Purity, Identity & Batch Checks

How to Read a Peptide COA: Purity, Identity & Batch Checks

How to Read a Peptide Certificate of Analysis (COA)

A peptide certificate of analysis, or COA, documents laboratory results for an identified sample or batch. It can help explain which material was tested, how it was analysed, and what the results show.

Understanding a peptide COA involves more than checking a purity percentage. Batch identification, analytical methods, and the distinction between identity and purity all affect how a report should be interpreted.

This guide explains the main sections of a peptide lab report, common terminology, and the limits of analytical testing.

What Is a Peptide COA?

A peptide COA is a document reporting the results of specified analytical tests. Depending on its scope, it may include:

  • Product and sample identification.
  • A batch or lot number.
  • Testing dates and laboratory details.
  • Analytical methods.
  • Acceptance criteria and measured results.
  • Supporting chromatograms or mass spectra.

Not every COA contains the same tests. A report covering identity and chromatographic purity should not be assumed to cover quantity, sterility, or other characteristics.

The first question to ask is: what does this particular report actually measure?

How to Read a Peptide COA: Step by Step

Annotated example of a peptide certificate of analysis showing batch identifiers, test methods, identity and purity results, specification vs. result, and supporting chromatogram data.
Illustrative example only. Does not describe any real product, batch or laboratory.

1. Check the Product and Batch Identification

Start with the identifying information at the top of the report.

The product name describes the material being reported. The batch or lot number connects the documentation to a particular production batch. A laboratory sample number or report identifier provides a separate reference for the analysis.

Check that these details are consistent with the relevant product documentation.

For example, a COA listing batch ABC-001 does not automatically apply to material labelled ABC-002, even if the product name is identical.

Also distinguish between a report for bulk raw material and one for a finished packaged sample. Results describe the material submitted for testing; they do not automatically establish the condition of material after subsequent handling or packaging.

2. Identify the Tests Performed

Two methods commonly used in peptide analysis are high-performance liquid chromatography, or HPLC, and mass spectrometry, or MS.

They provide different types of information.

Test or measurement Main purpose Important limitation
HPLC purity analysis Assesses the relative chromatographic response of separated components Does not automatically measure every substance in the sample
Mass spectrometry Provides mass-related evidence supporting identity assessment Matching mass alone does not establish every structural detail
Quantitative assay Measures an amount or concentration using a specified method Must be interpreted using the stated units, calibration, and calculation

HPLC and MS are often used together because separation data and mass-related data answer complementary questions. [1]

3. Read the Purity Result With Its Method

A peptide COA may report a result such as “99.0% purity by HPLC.”

Where purity is calculated using peak-area normalization, this generally describes the target peak’s proportion of the integrated detector response under the stated analytical conditions.

It does not automatically mean that 99.0% of the total powder weight is the intended peptide.

To interpret the result, look for:

  • The analytical method or method reference.
  • Detector conditions, where provided.
  • A chromatogram and integration table.
  • Identification of the peak used in the calculation.
  • The specification against which the result was assessed.

Components that are not adequately separated or detected may not be represented accurately by the reported percentage. The result should therefore be read as a measurement within the method’s capabilities.

4. Review the Identity Results

Mass spectrometry can provide evidence that the sample is consistent with the expected peptide.

A report may list an expected molecular mass, an observed mass, or mass-to-charge values from the spectrum.

These values need to be compared on the same basis. A mass-to-charge signal is not directly interchangeable with a calculated neutral molecular mass.

Agreement between expected and observed results supports identity assessment. However, basic mass agreement alone does not prove the complete amino acid sequence or distinguish every possible structural variation.

If the report claims sequence confirmation, check which analytical evidence supports that conclusion.

5. Distinguish Purity From Peptide Content

Peptide purity, peptide content, and total sample weight are related but different measurements.

A dried preparation can contain water, counterions, residual solvents, and other non-peptide components. These contribute to its weight and may not be adequately reflected in an HPLC purity result.

MilliporeSigma’s technical guidance distinguishes net peptide content from chromatographic purity. [2]

For that reason, a high purity percentage alone does not verify the stated quantity of target peptide in a container.

Where quantity matters for a laboratory application, look for an appropriate quantitative measurement rather than inferring the amount from purity alone.

6. Check Specifications and Supporting Data

A specification is the acceptance criterion used to evaluate a result. The measured result shows what the analysis found.

For example:

Report field Illustrative entry
Test HPLC purity
Specification At least 98.0%
Result 99.0%
Assessment Meets the stated specification

These figures are examples only and do not describe an Iron Health Peptides product or establish a universal testing standard.

A numerical result is generally more informative than “Pass” alone. Supporting chromatograms, spectra, and method details can provide additional context.

A summary COA may not contain all underlying records. If information is missing, request clarification or supporting documentation before drawing conclusions.

What a Peptide COA Does Not Prove

A COA supports conclusions only within the scope of the tests performed.

Identity and chromatographic purity results do not, by themselves, establish:

  • Sterility or endotoxin levels.
  • The absence of every possible contaminant.
  • Stability throughout storage and transportation.
  • Safety or effectiveness in humans.
  • Suitability for medical use.
  • Health Canada authorization.

These are separate questions requiring different evidence. A laboratory report is not a substitute for regulatory authorization or clinical evaluation.

Health Canada states that unauthorized peptide drugs have not been assessed for safety, effectiveness, and quality. Labelling a product “for research use only” does not exempt it from applicable regulatory requirements. [3]

Common Peptide COA Red Flags

The following documentation gaps warrant clarification:

  • Missing or mismatched batch details
    The report cannot be clearly connected to the relevant material.
  • A purity percentage without an identified method
    There is insufficient information to understand what the number represents.
  • Unclear laboratory information
    The issuing organization or report reference cannot be readily identified.
  • Inconsistent sample details
    Product names, dates, or identifiers differ across the report and related records.
  • Conclusions that exceed the testing
    Purity or identity results are presented as proof of human safety, sterility, or regulatory approval.

A documentation gap does not automatically establish that a report is invalid. It means further information is needed.

Frequently Asked Questions About Peptide COAs

Is a peptide COA the same as a purity report?

Not necessarily. A COA may include multiple tests, while a purity report may cover only one analytical measurement. Check the tests listed rather than relying on the document title.

What does 99% purity mean on a peptide COA?

It usually means the target peak made up 99% of the integrated detector response in an HPLC analysis, under the stated conditions. It does not mean 99% of the powder’s total weight is the intended peptide. Water, counterions and other non-peptide components may not be reflected in the purity result.

What is the difference between peptide purity and net peptide content?

Purity describes the target peptide relative to the other components the analytical method detects, typically by HPLC. Net peptide content describes how much of the total sample weight is peptide rather than water, counterions or other non-peptide material. They are separate measurements, and neither can be inferred from the other.

Does 99% HPLC purity establish human safety?

No. Chromatographic purity does not establish human safety, effectiveness, sterility, or regulatory authorization.

Does a COA confirm the amount of peptide in a container?

Only if the report includes an appropriate quantitative measurement supporting that amount. Purity alone does not verify quantity.

Can the same COA apply to different batches?

A batch-specific report should be traceable to the batch identified. Do not assume results apply to another batch without supporting documentation.

How do I check that a COA matches the material I have?

Compare the batch or lot number on the report with the batch on the product documentation. A matching product name alone is not enough, because results for one batch do not automatically apply to another.

How can a laboratory report be verified?

Where available, use the issuing laboratory’s official verification service or contact it through independently located contact details. Provide the report or sample reference and ask what information it can confirm.

Peptide COA Review Checklist

When reviewing a peptide certificate of analysis, check that:

  • Product, batch, and sample identifiers are clear.
  • Laboratory and report details are identifiable.
  • Methods and results are stated.
  • Identity, purity, and quantity are distinguished.
  • Specifications are separated from measured results.
  • Supporting data are available where needed.
  • Conclusions remain within the scope of the analysis.

A useful peptide COA connects an identifiable sample with clearly described testing and interpretable results. Understanding those connections helps readers evaluate laboratory documentation without assuming that a single percentage answers every question.

This article provides general information about analytical documentation. It does not establish the suitability of any product for human or veterinary use.

Sources

  1. Thermo Fisher Scientific: Using Mass Spectrometry for Oligonucleotide and Peptides
  2. MilliporeSigma: Peptide Sample Amount Determination
  3. Health Canada: Think twice before injecting peptides bought online

0 comments

Leave a comment

Please note, comments need to be approved before they are published.